Modification of chronic manganese poisoning. Treatment with L-dopa or 5-OH tryptophane.
D006916:5-Hydroxytryptophan / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D002908:Chronic Disease; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D020149:Manganese Poisoning; D008875:Middle Aged; D008906:Mining; D009135:Muscular Diseases / Q000188:drug therapy / Q000209:etiology; D009461:Neurologic Manifestations; D009784:Occupational Diseases; D010919:Placebos; D011041:Poisoning / Q000188:drug therapy; D012018:Reflex
D010919:Placebos; D004295:Dihydroxyphenylalanine; D006916:5-Hydroxytryptophan